1887

Graphical Abstract

 Graphical abstract 

, an opportunistic fungal pathogen. (a) Unable to form hyphae, relies on tissue disruption to invade and disseminate host. (b) Calcofluor-white cells, 60X objective. (c) Colony morphology on YPD.

 

 

Abstract

is a fungal microbe associated with multiple vertebrate microbiomes and their terrestrial environments. In humans, the species has emerged as an opportunistic pathogen that now ranks as the second-leading cause of candidiasis in Europe and North America (Beardsley . 2024, 62). People at highest risk of infection include the elderly, immunocompromised individuals and/or long-term residents of hospital and assisted-living facilities. is intrinsically drug-resistant, metabolically versatile and able to avoid detection by the immune system. Analyses of its 12.3 Mb genome indicate a stable pangenome Marcet-Houben . ( 2022, 20) and phylogenetic affinity with . Recent phylogenetic analyses suggest reclassifying as Lakashima and Sugita ( 2022, 63: 119-132).

Funding
This study was supported by the:
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Award 1R01AI 136992-01A1)
    • Principle Award Recipient: GavinSherlock
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.001518
2024-11-26
2024-12-08
Loading full text...

Full text loading...

/deliver/fulltext/micro/170/11/mic001518.html?itemId=/content/journal/micro/10.1099/mic.0.001518&mimeType=html&fmt=ahah

References

  1. Anderson HW. Yeast-like fungi of the human intestinal tract. J Infect Dis 1917; 21:341–354 [View Article]
    [Google Scholar]
  2. Kumar K, Askari F, Sahu MS, Kaur R. Candida glabrata: a lot more than meets the eye. Microorganisms 2019; 7:39 [View Article]
    [Google Scholar]
  3. Takashima M, Sugita T. Taxonomy of pathogenic yeasts Candida, Cryptococcus, Malassezia, and Trichosporoncurrent status, future perspectives, and proposal for transfer of six Candida species to the genus Nakaseomyces. Med Mycol J 2022; 63:119–132 [View Article]
    [Google Scholar]
  4. Dujon B, Sherman D, Fischer G, Durrens P, Casaregola S et al. Genome evolution in yeasts. Nature 2004; 430:35–44 [View Article] [PubMed]
    [Google Scholar]
  5. Angoulvant A, Guitard J, Hennequin C. Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance. FEMS Yeast Res 2016; 16:fov114 [View Article] [PubMed]
    [Google Scholar]
  6. Gabaldón T, Fairhead C. Genomes shed light on the secret life of Candida glabrata: not so asexual, not so commensal. Curr Genet 2019; 65:93–98 [View Article] [PubMed]
    [Google Scholar]
  7. Xu Z, Green B, Benoit N, Schatz M, Wheelan S et al. De novo genome assembly of Candida glabrata reveals cell wall protein complement and structure of dispersed tandem repeat arrays. Mol Microbiol 2020; 113:1209–1224 [View Article] [PubMed]
    [Google Scholar]
  8. Cormack BP, Falkow S. Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata. Genetics 1999; 151:979–987 [View Article] [PubMed]
    [Google Scholar]
  9. Turner SA, Butler G. The Candida pathogenic species complex. Cold Spring Harb Perspect Med 2014; 4:a019778 [View Article] [PubMed]
    [Google Scholar]
  10. Marcet-Houben M, Alvarado M, Ksiezopolska E, Saus E, de Groot PWJ et al. Chromosome-level assemblies from diverse clades reveal limited structural and gene content variation in the genome of Candida glabrata. BMC Biol 2022; 20:226 [View Article] [PubMed]
    [Google Scholar]
  11. Hassan Y, Chew SY, Than LTL. Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival. J Fungi (Basel) 2021; 7:667 [View Article] [PubMed]
    [Google Scholar]
  12. Kaur R, Domergue R, Zupancic ML, Cormack BP. A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol 2005; 8:378–384 [View Article] [PubMed]
    [Google Scholar]
  13. Healey KR, Jimenez Ortigosa C, Shor E, Perlin DS. Genetic drivers of multidrug resistance in Candida glabrata. Front Microbiol 2016; 7:1995 [View Article] [PubMed]
    [Google Scholar]
  14. Pountain AW, Collette JR, Farrell WM, Lorenz MC. Interactions of both pathogenic and nonpathogenic CUG clade Candida species with macrophages share a conserved transcriptional landscape. mBio 2021; 12:e0331721 [View Article] [PubMed]
    [Google Scholar]
  15. Al-Yasiri MH, Normand A-C, L’Ollivier C, Lachaud L, Bourgeois N et al. Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls. Sci Rep 2016; 6:36157 [View Article] [PubMed]
    [Google Scholar]
  16. Panackal AA, Gribskov JL, Staab JF, Kirby KA, Rinaldi M et al. Clinical significance of azole antifungal drug cross-resistance in Candida glabrata. J Clin Microbiol 2006; 44:1740–1743 [View Article] [PubMed]
    [Google Scholar]
  17. Beardsley J, Kim HY, Dao A, Kidd S, Alastruey-Izquierdo A et al. Candida glabrata (Nakaseomyces glabrata): a systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List. Med Mycol 2024; 62:myae041 [View Article] [PubMed]
    [Google Scholar]
  18. Gale AN, Pavesic MW, Nickels TJ, Xu Z, Cormack BP et al. Redefining pleiotropic drug resistance in a pathogenic yeast: Pdr1 functions as a sensor of cellular stresses in Candida glabrata. mSphere 2023; 8:e0025423 [View Article] [PubMed]
    [Google Scholar]
  19. Nikolov VN, Malavia D, Kubota T. SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes. Nat Commun 2022; 13:1968 [View Article] [PubMed]
    [Google Scholar]
  20. Duxbury SJN, Bates S, Beardmore RE, Gudelj I. Evolution of drug-resistant and virulent small colonies in phenotypically diverse populations of the human fungal pathogen Candida glabrata. Proc Biol Sci 2020; 287:20200761 [View Article] [PubMed]
    [Google Scholar]
  21. Badrane H, Cheng S, Dupont CL, Hao B, Driscoll E et al. Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood cultures. Nat Commun 2023; 14:5918 [View Article] [PubMed]
    [Google Scholar]
  22. Arastehfar A, Daneshnia F, Hovhannisyan H, Fuentes D, Cabrera N et al. Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness. mBio 2023; 14:e0118023 [View Article] [PubMed]
    [Google Scholar]
  23. Kaur R, Ma B, Cormack BP. A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata. Proc Natl Acad Sci U S A 2007; 104:7628–7633 [View Article] [PubMed]
    [Google Scholar]
  24. Rasheed M, Battu A, Kaur R. Aspartyl proteases in Candida glabrata are required for suppression of the host innate immune response. J Biol Chem 2018; 293:6410–6433 [View Article] [PubMed]
    [Google Scholar]
  25. Seider K, Brunke S, Schild L, Jablonowski N, Wilson D et al. The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol 2011; 187:3072–3086 [View Article] [PubMed]
    [Google Scholar]
  26. Kasper L, Seider K, Hube B. Intracellular survival of Candida glabrata in macrophages: immune evasion and persistence. FEMS Yeast Res 2015; 15:fov042 [View Article] [PubMed]
    [Google Scholar]
  27. Kasper L, Seider K, Gerwien F, Allert S, Brunke S et al. Identification of Candida glabrata genes involved in pH modulation and modification of the phagosomal environment in macrophages. PLoS One 2014; 9:e96015 [View Article] [PubMed]
    [Google Scholar]
  28. Kumar K, Pareek A, Kaur R. SWI/SNF complex-mediated chromatin remodeling in Candida glabrata promotes immune evasion. iScience 2024; 27:109607 [View Article] [PubMed]
    [Google Scholar]
/content/journal/micro/10.1099/mic.0.001518
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error